Improvements in prescribing creates savings: NPS
Falling rates of prescribing of high dose statins and anti-dementia drugs is proof that programs aimed at improving the quality use of medicines are effective, NPS MedicineWise believes.
The NPS MedicineWise claimed credit for “improvements in appropriate prescribing” of the drugs in its annual evaluation report, released yesterday.
Dr Lynn Weekes (pictured), NPS MedicineWise CEO, said the report outlined the organisation’s success in creating both health and economic impacts.
“I’m proud of the good work we have done in the past financial year to enable people to make